JFS Wealth Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-91
Closed -$16K 594
2020
Q1
$16K Buy
91
+1
+1% +$188 ﹤0.01% 290
2019
Q4
$17K Hold
90
﹤0.01% 326
2019
Q3
$15K Hold
90
﹤0.01% 334
2019
Q2
$15K Buy
90
+1
+1% +$138 ﹤0.01% 336
2019
Q1
$13K Hold
89
﹤0.01% 341
2018
Q4
$12K Buy
89
+1
+1% +$164 ﹤0.01% 335
2018
Q3
$17K Hold
88
﹤0.01% 341
2018
Q2
$15K Hold
88
﹤0.01% 336
2018
Q1
$15K Buy
88
+1
+1% +$168 ﹤0.01% 343
2017
Q4
$14K Hold
87
﹤0.01% 359
2017
Q3
$18K Hold
87
﹤0.01% 334
2017
Q2
$21K Buy
87
+1
+1% +$235 0.01% 299
2017
Q1
$18K Hold
86
﹤0.01% 320
2016
Q4
$18K Hold
86
﹤0.01% 320
2016
Q3
$20K Sell
86
-1,296
-94% -$317K 0.01% 326
2016
Q2
$319K Buy
1,382
+1,260
+1,033% +$291K 0.09% 122
2016
Q1
$33K Buy
122
+25
+26% +$7.16K 0.01% 276
2015
Q4
$30K Hold
97
0.01% 292
2015
Q3
$26K Buy
97
+11
+13% +$3.38K 0.01% 258
2015
Q2
$26K Buy
+86
New +$25.6K 0.01% 244

Other funds holding AGN

JFS Wealth Advisors's AGN Position: Q2 2020 in Review

JFS Wealth Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 91 shares — an estimated $16K sold.

JFS Wealth Advisors first reported a position in AGN in Q2 2015 and held it in 20 quarters. The position peaked at $319K in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • JFS Wealth Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • JFS Wealth Advisors sold 91 Allergan plc shares in Q2 2020, an estimated $16K.
  • JFS Wealth Advisors first reported a position in Allergan plc in Q2 2015 and held it in 20 quarters.
  • JFS Wealth Advisors's Allergan plc position peaked at $319K in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on JFS Wealth Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.